Retina Drug Co. Settles Investor Row For $29M
Investors in Ophthotech Corp. asked a New York federal judge Friday to approve a $29 million cash settlement they had reached with the biopharmaceutical company over claims that it misled shareholders...To view the full article, register now.
Already a subscriber? Click here to view full article